CVS Group

Overview

CVS Group plc started acquiring veterinary practices in 1999 and has grown to become one of the UK’s largest veterinary corporate groups. As a publicly traded company (LSE: CVSG), they are subject to shareholder pressure to deliver financial returns.

UK Presence

CVS operates around 500 veterinary practices across the UK, including first-opinion practices, specialist referral centres, and emergency clinics. They also own pet crematoria and veterinary diagnostic laboratories.

Business Model

Unlike private equity-backed competitors, CVS is publicly traded, meaning their financial performance is publicly reported. However, this also means pressure to deliver returns to shareholders can influence pricing and operational decisions.

Regulatory Matters

The CMA has examined several CVS acquisitions:

• The proposed acquisition of Quality Pet Care Ltd (The Vet) raised competition concerns
• CVS was included in the broader CMA veterinary market investigation, whose final report (March 2026) set out remedies covering ownership disclosure and pricing transparency

In July 2026 the government accepted all of the CMA’s recommendations, committing to replace the Veterinary Surgeons Act 1966 with new legislation that will license veterinary businesses and introduce a binding consumer redress scheme, expected to be delivered through a new veterinary ombudsman.

What Pet Owners Should Know

• As a public company, CVS publishes annual reports detailing their financial performance
• Individual practices may have less autonomy over pricing than independent practices
• CVS practices benefit from shared resources but may follow corporate protocols